This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Protalix BioTherapeutics Inc (PLX)

AMEX: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 86.40M 52.04M 27.00M 35.90M
Receivables 2.09M 1.41M 5.21M 9.24M
Inventories 7.96M 4.04M 279.00K 1.19M
Other Current Assets 1.46M 3.14M 0.00 0.00
Total Current Assets 97.90M 61.17M 32.49M 46.33M
Property, Plant & Equipment, Gross 32.03M 31.10M 29.42M 25.04M
Accumulated Depreciation & Depletion 18.32M 14.79M 11.15M 7.59M
Property, Plant & Equipment, Net 13.71M 16.31M 18.27M 17.45M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 1.72M 1.25M 1.04M 942.00K
Total Non-Current Assets 15.43M 17.56M 19.31M 18.40M
Liabilities & Shareholder Equity
Total Assets 113.33M 78.73M 51.80M 64.73M
Accounts Payable 17.33M 6.83M 12.57M 14.34M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 5.71M 0.00 0.00
Total Current Liabilities 26.70M 25.76M 18.69M 18.90M
Long Term Debt 67.05M 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 46.54M 56.33M 59.19M 57.15M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 113.58M 56.33M 59.19M 57.15M
Total Liabilities 140.28M 82.08M 77.88M 76.05M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity -26.95M -3.36M -26.08M -11.32M
Common Par 93.00K 93.00K 86.00K 81.00K
Additional Paid In Capital 184.35M 180.14M 145.81M 124.04M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -211.38M -183.60M -171.98M -135.45M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 40.10M -3.36M -26.08M -11.32M
Total Equity -26.95M -3.36M -26.08M -11.32M
Total Liabilities & Stock Equity 113.33M 78.73M 51.80M 64.73M
Total Common Shares Outstanding 93.49M 93.49M 85.63M 80.84M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 92.37M 90.85M 84.65M 80.96M
Diluted Weighted Shares Outstanding 92.37M 90.85M 84.65M 80.96M
Number of Employees 260 266 235 240
Number of Part-Time Employees 0 0 0 0
PLX News

PLX Protalix BioTherapeutics Inc

Analysts Ratings for PLX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET PLX ANALYST REPORT

Brokerage Partners

PLX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs